These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20804199)

  • 1. Inhalation by design: novel ultra-long-acting β(2)-adrenoreceptor agonists for inhaled once-daily treatment of asthma and chronic obstructive pulmonary disease that utilize a sulfonamide agonist headgroup.
    Glossop PA; Lane CA; Price DA; Bunnage ME; Lewthwaite RA; James K; Brown AD; Yeadon M; Perros-Huguet C; Trevethick MA; Clarke NP; Webster R; Jones RM; Burrows JL; Feeder N; Taylor SC; Spence FJ
    J Med Chem; 2010 Sep; 53(18):6640-52. PubMed ID: 20804199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhalation by design: novel tertiary amine muscarinic M₃ receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.
    Glossop PA; Watson CA; Price DA; Bunnage ME; Middleton DS; Wood A; James K; Roberts D; Strang RS; Yeadon M; Perros-Huguet C; Clarke NP; Trevethick MA; Machin I; Stuart EF; Evans SM; Harrison AC; Fairman DA; Agoram B; Burrows JL; Feeder N; Fulton CK; Dillon BR; Entwistle DA; Spence FJ
    J Med Chem; 2011 Oct; 54(19):6888-904. PubMed ID: 21870878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The discovery of indole-derived long acting beta2-adrenoceptor agonists for the treatment of asthma and COPD.
    Brown AD; Bunnage ME; Glossop PA; Holbrook M; Jones RD; Lane CA; Lewthwaite RA; Mantell S; Perros-Huguet C; Price DA; Webster R
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6188-91. PubMed ID: 17897826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationships of long-acting beta2 adrenergic receptor agonists incorporating arylsulfonamide groups.
    Procopiou PA; Barrett VJ; Bevan NJ; Biggadike K; Butchers PR; Coe DM; Conroy R; Edney DD; Field RN; Ford AJ; Guntrip SB; Looker BE; McLay IM; Monteith MJ; Morrison VS; Mutch PJ; Richards SA; Sasse R; Smith CE
    J Med Chem; 2009 Apr; 52(8):2280-8. PubMed ID: 19317397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicted heart rate effect of inhaled PF-00610355, a long acting β-adrenoceptor agonist, in volunteers and patients with chronic obstructive pulmonary disease.
    Diderichsen PM; Cox E; Martin SW; Cleton A; Ribbing J
    Br J Clin Pharmacol; 2013 Nov; 76(5):752-62. PubMed ID: 23323609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The discovery of long-acting saligenin β₂ adrenergic receptor agonists incorporating hydantoin or uracil rings.
    Procopiou PA; Barrett VJ; Bevan NJ; Butchers PR; Conroy R; Emmons A; Ford AJ; Jeulin S; Looker BE; Lunniss GE; Morrison VS; Mutch PJ; Perciaccante R; Ruston M; Smith CE; Somers G
    Bioorg Med Chem; 2011 Jul; 19(14):4192-201. PubMed ID: 21696967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From libraries to candidate: the discovery of new ultra long-acting dibasic β₂-adrenoceptor agonists.
    Alcaraz L; Bailey A; Cadogan E; Connolly S; Jewell R; Jordan S; Kindon N; Lister A; Lawson M; Mullen A; Dainty I; Nicholls D; Paine S; Pairaudeau G; Stocks MJ; Thorne P; Young A
    Bioorg Med Chem Lett; 2012 Jan; 22(1):689-95. PubMed ID: 22079756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multivalent approach to the discovery of long-acting β(2)-adrenoceptor agonists for the treatment of asthma and COPD.
    Jacobsen JR; Choi SK; Combs J; Fournier EJ; Klein U; Pfeiffer JW; Thomas GR; Yu C; Moran EJ
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1213-8. PubMed ID: 22178551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of a potent, orally bioavailable beta(3) adrenergic receptor agonist, (R)-N-[4-[2-[[2-hydroxy-2-(3-pyridinyl)ethyl]amino]ethyl]phenyl]-4-[4 -[4-(trifluoromethyl)phenyl]thiazol-2-yl]benzenesulfonamide.
    Mathvink RJ; Tolman JS; Chitty D; Candelore MR; Cascieri MA; Colwell LF; Deng L; Feeney WP; Forrest MJ; Hom GJ; MacIntyre DE; Miller RR; Stearns RA; Tota L; Wyvratt MJ; Fisher MH; Weber AE
    J Med Chem; 2000 Oct; 43(21):3832-6. PubMed ID: 11052788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The discovery of adamantyl-derived, inhaled, long acting beta(2)-adrenoreceptor agonists.
    Brown AD; Bunnage ME; Glossop PA; James K; Jones R; Lane CA; Lewthwaite RA; Mantell S; Perros-Huguet C; Price DA; Trevethick M; Webster R
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1280-3. PubMed ID: 18226900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of a rapidly metabolized, long-acting β(2) adrenergic receptor agonist with a short onset time incorporating a sulfone group suitable for once-daily dosing.
    Procopiou PA; Barrett VJ; Biggadike K; Butchers PR; Craven A; Ford AJ; Guntrip SB; Holmes DS; Hughes SC; Jones AE; Looker BE; Mutch PJ; Ruston M; Needham D; Smith CE
    J Med Chem; 2014 Jan; 57(1):159-70. PubMed ID: 24359185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formoterol dry-powder inhaler for the treatment of asthma and chronic obstructive pulmonary disease.
    Prenner BM
    Expert Opin Pharmacother; 2007 Dec; 8(17):3069-84. PubMed ID: 18001266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RP 58802B, a long-acting beta 2-adrenoceptor agonist: assessment of antiasthma activity in the guinea-pig in vivo.
    Underwood SL; Lewis SA; Raeburn D
    Pulm Pharmacol; 1992 Sep; 5(3):203-12. PubMed ID: 1280178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizing systemic exposure of inhaled drugs: application to the long-acting β2-agonist PF-00610355.
    Diderichsen PM; Cox E; Martin SW; Cleton A; Ribbing J
    Clin Pharmacokinet; 2013 Jun; 52(6):443-52. PubMed ID: 23494982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient conversion of a nonselective norepinephrin reuptake inhibitor into a dual muscarinic antagonist-β₂-agonist for the treatment of chronic obstructive pulmonary disease.
    Osborne R; Clarke N; Glossop P; Kenyon A; Liu H; Patel S; Summerhill S; Jones LH
    J Med Chem; 2011 Oct; 54(19):6998-7002. PubMed ID: 21863888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The discovery of long-acting saligenin β₂ adrenergic receptor agonists incorporating a urea group.
    Procopiou PA; Barrett VJ; Ford AJ; Looker BE; Lunniss GE; Needham D; Smith CE; Somers G
    Bioorg Med Chem; 2011 Oct; 19(20):6026-32. PubMed ID: 21925889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining inhaled glucocorticoids and long acting beta(2)-adrenoceptor agonists in asthma and COPD.
    Knox AJ; Mortimer K
    Br J Pharmacol; 2008 Mar; 153(6):1085-6. PubMed ID: 18223662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salmeterol, a novel, long-acting beta 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo.
    Ball DI; Brittain RT; Coleman RA; Denyer LH; Jack D; Johnson M; Lunts LH; Nials AT; Sheldrick KE; Skidmore IF
    Br J Pharmacol; 1991 Nov; 104(3):665-71. PubMed ID: 1686740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting beta-agonists and their association with inhaled corticosteroids in COPD.
    Fuso L; Mores N; Valente S; Malerba M; Montuschi P
    Curr Med Chem; 2013; 20(12):1477-95. PubMed ID: 23409722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of potent and selective beta(3) adrenergic receptor agonists containing acylsulfonamide, sulfonylsulfonamide, and sulfonylurea carboxylic acid isosteres.
    Uehling DE; Donaldson KH; Deaton DN; Hyman CE; Sugg EE; Barrett DG; Hughes RG; Reitter B; Adkison KK; Lancaster ME; Lee F; Hart R; Paulik MA; Sherman BW; True T; Cowan C
    J Med Chem; 2002 Jan; 45(3):567-83. PubMed ID: 11806709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.